Concepedia

Chang Li

CL

Statistics

Publications

16

Citations

599

H-Index

13

Active since

2016

Affiliations

University of Washington(Current)

University of Washington Medical Center

Fred Hutch Cancer Center

G. Papanikolaou General Hospital

Aristotle University of Thessaloniki

Chang Li is an author at University of Washington specializing in therapeutic genome editing, gene therapy, and life sciences.

ORCID

Publications per year

2016–2024

16

Publications

16

In vivo HSPC gene therapy with base editors allows for efficient reactivation of fetal γ-globin in β-YAC mice

Chang Li, Aphrodite Georgakopoulou, Arpit Mishra et al. · Blood Advances · 2021 · 88 citations · Full text

, , +16

Reactivation of γ-globin in adult β-YAC mice after ex vivo and in vivo hematopoietic stem cell genome editing

Chang Li, Nikoletta Psatha, Pavel Sova et al. · Blood · 2018 · 79 citations · Full text

, , +13

<i>In vivo</i> HSC prime editing rescues Sickle Cell Disease in a mouse model

Chang Li, Aphrodite Georgakopoulou, Gregory A. Newby et al. · Blood · 2023 · 72 citations · Full text

, , +17

In Vivo HSC Gene Therapy Using a Bi-modular HDAd5/35++ Vector Cures Sickle Cell Disease in a Mouse Model

Chang Li, Hongjie Wang, Aphrodite Georgakopoulou et al. · Molecular Therapy · 2020 · 70 citations · Full text

, , +15

Targeted Integration and High-Level Transgene Expression in AAVS1 Transgenic Mice after In Vivo HSC Transduction with HDAd5/35++ Vectors

Chang Li, Arpit Mishra, Sucheol Gil et al. · Molecular Therapy · 2019 · 42 citations · Full text

, , +17

1–5 of 16